Friday, 16 October 2026European Markets

IMERYS And TITAN CEMENT Have A High Dividend Yield And Return On Equity In The Basic Materials Sector.

Loading stream...

(vianews) - imerys (nk.pa) is among this list of stock assets with the highest dividend rate and return on equity on the basic materials sector.

financial asset price forward dividend yield return on equity
imerys (nk.pa) €31.58 4.5% 0.27%
titan cement (titc.br) €26.15 3.19% 18.13%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. imerys (nk.pa)

4.5% forward dividend yield and 0.27% return on equity

imerys s.a. provides mineral-based specialty solutions for various industries worldwide. the company provides additives for paints, coatings, adhesives, caulks, sealants, and rubber; minerals for technical ceramics and traditional ceramics; functional additives for plastics and thermoset; high-performance binders for dry mix mortars and floor screeds; fillers and coatings for paper, board, and packaging applications; filtration agents for liquids and blood plasma; pharmaceutical diluents, coloring agents, processing aids, glidants, and lubricants for tablet production; engineered minerals for cosmetic industry; food additives to preserve flavor; coating agents to improve fertilizer fow; mineral-based cat litters; alumina for high-performance abrasives and graphite in brake pads; and carbon black for conductivity in onboard data systems. the company also offers minerals used to produce high purity silicon metal for electronics and solar panels; graphite and carbon-based solutions for industrial applications; mineral solutions for batteries and energy storage; refractory minerals and solutions for high-temperature processes; and alumina and zirconia for abrasives. it serves construction and infrastructure, consumer and health care, automotive and transportation, energy and electronics, and industry and equipment industries. the company was incorporated in 1880 and is headquartered in paris, france. the company is a subsidiary of belgian securities bv.

earnings per share

as for profitability, imerys has a trailing twelve months eps of €0.09.

pe ratio

imerys has a trailing twelve months price to earnings ratio of 350.89. meaning, the purchaser of the share is investing €350.89 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 0.27%.

more news about imerys.

2. titan cement (titc.br)

3.19% forward dividend yield and 18.13% return on equity

titan cement international s.a., together with its subsidiaries, produces, distributes, and trades in a range of construction materials in greece and western europe, north america, southeastern europe, and the eastern mediterranean. the company provides cement; ready-mix concrete; aggregates and coarse materials, including sand, gravel, crushed stone, and recycled concrete; and other building materials, such as dry mortars, building blocks, fly ash, and other concrete products for the construction of roads, bridges, airports, hospitals, schools, residential housing, commercial buildings, social projects, etc. it is also involved in the import and distribution of cement; processing of fly ash; sale of fly ash processing equipment; quarries; real estate brokerage services; engineering design services for solid and liquid waste facilities; and alternative fuels. in addition, the company provides trading, technical and business, port, financial, preventing maintenance, insurance, and transportation services; owns and develops real estate properties; rents and leases machines, equipment, and material goods; and designs, manufactures, and markets proprietary separation equipment for dry powders and the recycling of waste streams. titan cement international s.a. was founded in 1902 and is based in brussels, belgium.

earnings per share

as for profitability, titan cement has a trailing twelve months eps of €3.59.

pe ratio

titan cement has a trailing twelve months price to earnings ratio of 7.28. meaning, the purchaser of the share is investing €7.28 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 18.13%.

yearly top and bottom value

titan cement's stock is valued at €26.15 at 02:30 est, under its 52-week high of €27.05 and way above its 52-week low of €14.60.

volume

today's last reported volume for titan cement is 5774 which is 54.09% below its average volume of 12577.

volatility

titan cement's last week, last month's, and last quarter's current intraday variation average was a negative 0.29%, a positive 0.31%, and a positive 1.21%.

titan cement's highest amplitude of average volatility was 2.20% (last week), 1.12% (last month), and 1.21% (last quarter).

more news about titan cement.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,378 source documents archived
Query this data → isubstrate.com